Not only is B&L going to buy out the royalty stream for the quinalone, they are an excellent candidate to license BromSite in additon to purchasing the company at some point.
At this time, I would put a buy rec on the stock. When the fund, Coliseum Capital Management, LLC, has completed their selling program, the stock will be free to gain value.
I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.